Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

Juzot, Cécile; Isvy-Joubert, Anne; Khammari, Amir; Knol, Anne-Chantal; Nguyen, Jean-Michel; Dreno, Brigitte

Juzot, Cécile; Isvy-Joubert, Anne; Khammari, Amir; Knol, Anne-Chantal; Nguyen, Jean-Michel; Dreno, Brigitte.

Affiliation

Juzot C; Department of Dermatology, Nantes University Hospital, 1 place Alexis Ricordeau, 44093 Nantes Cedex 1, France
Isvy-Joubert A; Department of Dermatology, Nantes University Hospital, 1 place Alexis Ricordeau, 44093 Nantes Cedex 1, France
Khammari A; Department of Dermatology, Nantes University Hospital, 1 place Alexis Ricordeau, 44093 Nantes Cedex 1, France
Knol AC; CRCNA, INSERM U892, CNRS 6299, 9 Quai Moncousu, 44093 Nantes, France
Nguyen JM; CRCNA, INSERM U892, CNRS 6299, 9 Quai Moncousu, 44093 Nantes, France
Dreno B; CRCNA, INSERM U892, CNRS 6299, 9 Quai Moncousu, 44093 Nantes, France

Eur J Dermatol ; 32(3): 401-407, 2022 05 01.

Article in En | MEDLINE | ID: mdl-36065537

Subject(s)

Carcinoma, Basal Cell; Skin Neoplasms; Anilides; Carcinoma, Basal Cell/drug therapy; Carcinoma, Basal Cell/pathology; Hamartoma Syndrome, Multiple; Humans; Neoplasm Recurrence, Local/drug therapy; Pyridines; Skin Neoplasms/pathology

Key words

basal cell carcinoma; Gorlin syndrome; hedgehog pathway inhibitor; long-term; vismodegib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Dermatol Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: France Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google